JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grimaldi, M. E.
Right arrow Articles by Penniston, J. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grimaldi, M. E.
Right arrow Articles by Penniston, J. T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 271, Number 43, Issue of October 25, 1996 pp. 26995-26997
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

Deletion of Amino Acid Residues 18-75 Inactivates the Plasma Membrane Ca2+ Pump*

(Received for publication, July 9, 1996, and in revised form, July 29, 1996)

Mirta E. Grimaldi Dagger , Hugo P. Adamo Dagger §, Alcides F. Rega Dagger and John T. Penniston

From the Dagger  Instituto de Química y Fisicoquímica Biológicas-Facultad de Farmacia y Bioquímica (Universidad de Buenos Aires), Junin 956, 1113 Capital Federal, Buenos Aires, Argentina and the  Department of Biochemistry and Molecular Biology, Mayo Clinic/Foundation, Rochester, Minnesota 55905

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES


ABSTRACT

A mutant of the plasma membrane Ca2+ pump hPMCA4b(d18-75)(ct120) containing a deletion of the N-terminal amino acid residues 18-75 and lacking the C-terminal 120 amino acid residues was expressed in COS-1 cells. The deletion in the N-terminal region did not significantly affect the level of expression of the Ca2+ pump. Tryptic digestion of the hPMCA4b(d18-75)(ct120) mutant resulted in the appearance of the same fragments obtained by proteolysis of the hPMCA4b(ct120) enzyme, suggesting that deletion of residues 18-75 neither impeded the insertion in the membrane nor extensively affected the folding of the mutant protein. The functional competence of the hPMCA4b(d18-75)(ct120) enzyme was examined by measuring the Ca2+ transport and the Ca2+ ATPase activity of COS-1 cell microsomes expressing the mutant protein. Both tests proved the mutant to be inactive. Under conditions in which hPMCA4b(ct120) becomes phosphorylated, hPMCA4b(d18-75)(ct120) was incapable of reacting with ATP and Ca2+ to form the phosphoenzyme. Taken together these results suggest that the segment of amino acids 18-75 is essential for the activity of the plasma membrane Ca2+ pump.


INTRODUCTION

The Ca2+ pump from plasma membranes (PMCA)1 is a calmodulin regulated, P2-type ATPase (1) responsible for maintaining the intracellular Ca2+ homeostasis in eukaryotic cells by actively extruding Ca2+ to the extracellular space. Four mammalian genes coding for different PMCA isoforms have been identified, each of them producing different mRNAs by alternative splicing processes (2). The PMCA polypeptide would transverse the lipid bilayer about 10 times, and most of the pump, including two major loops and both terminal ends, would be exposed to the cytosol (3). The PMCA contains regions highly conserved in all P-type ATPases and other regions that are distinctive of the PMCA because they are found only in the PMCA isoforms. The regions of the PMCA encompassing the aspartate residue that forms the phosphorylated intermediate (4) and the putative ATP binding site (5) belong to the type of highly conserved regions. In contrast the C-terminal region after the transmembrane segment 10, which is involved in the regulation of the activity of the enzyme by calmodulin (6), and the N-terminal region upstream the first transmembrane segment belong to the regions that are not homologous to that of the other P-type ATPases.

Recently a PMCA mutant called hPMCA4b(ct120) with a deletion of the C-terminal 120 residues including the calmodulin-binding site was expressed in COS-1 cells and found to be fully active, and as expected its activity no longer regulated by calmodulin (7).

We have now investigated the functional relevance of the N-terminal region of the PMCA, which extends from the initial methionine to about the beginning of the first transmembrane segment. With this aim, we constructed a mutant called hPMCA4b(d18-75)(ct120) by removing the nucleotide sequence coding for amino acids 18-75 from the cDNA of hPMCA4b(ct120). The measurements of the activity of the hPMCA4b(d18-75)(ct120) expressed in COS-1 cells indicate that the residues 18-75 are essential for a functional Ca2+ pump.


MATERIALS AND METHODS

Construction of the hPMCA4b Mutant cDNAs and Expression in COS-1 Cells

The construction of the cDNA of mutants hPMCA4b(ct120) and hPMCA4b(d18-75) was described previously, and the latter was called Hinm1 (3, 7). In addition to the deletion of residues 18-75, the presence of a new unique restriction site for MluI produced the replacement of serine 17 by threonine in the hPMCA4b(d18-75).

To obtain the hPMCA4b(d18-75)(ct120) mutant, the SalI-DraIII fragment was removed from hPMCA4b(d18-75) and cloned into h4PMCA(ct120). The wild-type and mutant cDNAs were cloned into the pMM2 vector (7). For protein expression, COS-1 cells (9) were transfected by the DEAE-dextran-chloroquine method (8) and harvested after 48 h. The microsomal fraction was isolated as described previously (7). Protein concentration was estimated by means of the Bio-Rad protein assay, with bovine serum albumin as a standard.

Detection of Expressed Ca2+ Pump Protein

SDS-electrophoresis and immunoblotting were carried out as described previously (10). Proteins were electrophoresed on a 7.5% acrylamide gel according to Laemmli (11) and subsequently transferred to Millipore Immobilon membranes. Nonspecific binding was blocked by incubating the membranes overnight at 4 °C in a solution of 160 mM NaCl, 0.05% Tween 20, and 1% nonfat dry milk. The membranes were incubated at 37 °C for 1 h with 5F10 monoclonal antibody from ascites fluid (dilution, 1:1000). For staining, biotinylated anti-mouse immunoglobulin G and avidin-horseradish peroxidase conjugate were used.

Ca2+ Transport Assay

Ca2+ uptake assays were performed as described previously (10). The reaction mixture contained 100 mM KCl, 50 mM Tris-HCl (pH 7.3 at 37 °C), 5 mM NaN3, 400 nM thapsigargin, 20 mM sodium phosphate, 6 mM ATP, 95 µM EGTA, and enough MgCl2 and CaCl2 to give a concentration of free Mg2+ of 800 µM and of free Ca2+ of 1 µM. The free concentrations of Mg2+ and Ca2+ were calculated using the program of Fabiato and Fabiato (12). Vesicles (5-10 µg of protein) were preincubated at 37 °C for 5 min, and the reaction was initiated by the addition of ATP. The reaction was terminated after 5 min by filtering the samples through a 0.45-µm filter. The 45Ca taken up by the vesicles was then determined by counting in a liquid scintillation counter. Uptake activities were expressed per mg of COS-1 cell membrane protein. The activity of the expressed Ca2+ pump was estimated after subtracting the activity of the endogenous enzyme from COS-1 cells transfected with the empty plasmid pMM2.

Ca2+-ATPase Assay

Ca2+ ATPase was measured by monitoring the [32P]Pi liberated from [gamma -32P]ATP (13). The reaction was carried out at 37 °C for 30 min. The reaction mixture contained 50 mM Tris-HCl (pH 7.4 at 37 °C), 100 mM KCl, 0.1 mM MgCl2, 0.1 mM EGTA, 0.1 mM ATP, 0.1 mM CaCl2, 5 mM NaN3, 0.5 mM ouabain, 4 µg/ml oligomycin, 400 nM thapsigargin, and 10 µg of membranes. The Ca2+ ATPase was taken as the difference of ATPase activities in the presence and the absence of Ca2+.

Detection of the Phosphorylated Intermediate

The phosphorylation reaction was carried out at 4 °C in medium containing 10 µg of microsomal protein, 100 mM KCl, 25 mM Tris-HCl (pH 7.4 at 4 °C), 400 nM thapsigargin, 5 mM MgCl2, 0.02 µM CaCl2, and 0.02 µM LaCl3 in a reaction volume of 0.25 ml. La3+ is known to stabilize the phosphoenzyme of the plasma membrane Ca2+ pump (14). The reaction was initiated by the addition of 1 µM [gamma -32P]ATP and terminated after 30 s with 1 ml of stopping solution containing 10% trichloroacetic acid, 10 mM Pi, and 1 mM cold ATP at 4 °C. After adding 50 µl of 1 mg/ml of bovine serum albumin, the denatured proteins were collected by centrifugation at 20,000 × g for 10 min, washed once more with stopping solution, and washed once with distilled water. The precipitated samples were dissolved in sample buffer and separated by SDS-electrophoresis in a 7% acrylamide gel according to Sarkadi et al. (15). After drying the gel, autoradiographs were produced.

Tryptic Digestion of Microsomes

Digestion of COS-1 microsomes with trypsin was done on ice in a medium containing 10 µg of microsomes, 0.1 mM EGTA, 50 mM Tris-HCl (pH 7.7 at 4 °C), 0.25 mM sucrose, 0.15 mM KCl, 2 mM dithiothreitol. The reaction was initiated by the addition of trypsin to give a final concentration of 20 µg/ml and terminated after 15 or 30 s with 10-fold excess of soybean trypsin inhibitor. Controls of undigested microsomes (0 s) were done by adding the inhibitor before the trypsin.


RESULTS

Expression of hPMCA4b(ct120) and hPMCA4b(d18-75)(ct120) in COS-1 Cells

COS-1 cells were transfected with the vector without insert or with either the hPMCA4b(ct120) or the hPMCA4b(d18-75)(ct120) DNAs. Different amounts of membranes from the transfected cells were submitted to SDS gel electrophoresis followed by immunoblotting using antibody 5F10, which recognizes an epitope located between amino acids 724-783 in the central part of the Ca2+ pump protein (3). The immunoblot is shown in Fig. 1. One band of about 140 kDa corresponding to the endogenous Ca2+ pump from COS-1 cells was detected in membranes from cells transfected with the empty vector pMM2. An additional band of about 120 kDa was observed in membranes from hPMCA4b(ct120) transfected cells. Membranes from COS-1 cells transfected with hPMCA4b(d18-75)(ct120) DNA showed a band at about 114 kDa, the expected molecular mass of the hPMCA4b(d18-75)(ct120) protein. The intensity of the bands of the hPMCA4b(ct120) and hPMCA4b(d18-75)(ct120) were close, indicating that both proteins were expressed at a similar level.


Fig. 1. Immunoblots of microsomes from COS-1 cells transfected with cDNA encoding hPMCA(d18-75)(ct120), hPMCA4b(ct120), or the empty vector pMM2. Monoclonal antibody 5F10 was used. The number on top of each lane indicates the number of micrograms of membrane protein loaded.
[View Larger Version of this Image (33K GIF file)]


Partial Proteolysis of the hPMCA4b(d18-75)(ct120) Protein

As a test for the topology of the hPMCA4b(d18-75)(ct120) Ca2+ pump, microsomes containing the expressed protein were exposed briefly to the action of trypsin. Fig. 2 shows an immunoblot of the proteolyzed membranes using antibody 5F10. In agreement with previous reports (7), the treatment of COS-1 membranes expressing hPMCA4b(ct120) with 20 µg/ml of trypsin for 30 s resulted in the appearance of a major band of approximately 76 kDa.


Fig. 2. Tryptic digestion of membranes from COS-1 cells transfected with cDNA encoding hPMCA(d18-75)(ct120), hPMCA4b(ct120), or the empty vector pMM2. Immunoblots using antibody 5F10 are shown. Tryptic digestion was performed as described under ``Materials and Methods.'' The number on top of each lane indicates the duration in seconds of the trypsin treatment.
[View Larger Version of this Image (58K GIF file)]


Because the N-terminal part of the molecule containing amino acid residues 1-315 is removed early during proteolysis and is not recognized by 5F10 (3) providing the insertion and folding of the enzyme was the same, differences are not expected between the proteolytic pattern of the hPMCA4b(ct120) and hPMCA(d18-75)(ct120). As shown in Fig. 2 this was indeed the case, suggesting that both the hPMCA4b(ct120) and the hPMCA(d18-75)(ct120) proteins exposed the same sites to trypsin and hence produced similar proteolytic fragments containing the epitope for antibody 5F10.

Activity of the hPMCA4b(d18-75)(ct120) Enzyme

Results in Table I show that the Ca2+ uptake of microsomes from cells transfected with the hPMCA4b(ct120) DNA was about 12 times higher than that from control microsomes from cells transfected with the empty vector. The Ca2+ transport activity of microsomes expressing the hPMCA4b(d18-75)(ct120) protein was not significantly different from that of the control, indicating that the mutant enzyme was not able to transport Ca2+. As also shown in Table I, the Ca2+ ATPase activity of microsomes from COS-1 cells transfected with the hPMCA4b(d18-75)(ct120) DNA was similar to that of the control, indicating that the hPMCA4b(d18-75)(ct120) was also not capable of hydrolyzing ATP in a Ca2+-dependent manner.

Table I.

Ca2+ transport and Ca2+ ATPase activities of microsomes isolated from cells transfected with PMM2, hPMCA4b(ct120) or hPMCA4b(d18-75)(ct120)

Ca2+ uptake and Ca2+ ATPase from COS-1 microsomes were estimated as described under ``Materials and Methods.'' Averages (± standard deviation) of duplicate measurements from three to five experiments done with different membrane preparations are shown.
DNA transfected Ca2+ transport Ca2+ ATPase

nmol Ca2+/mg membrane protein/min nmol Pi/mg membrane protein/min
pMM2 0.14  ± 0.12 0.45  ± 0.25
hPMCA4b(ct120) 1.80  ± 0.34 6.08  ± 1.08
hPMCA4b(d18-75)(ct120) 0.25  ± 0.12 0.33  ± 0.43

In control experiments (not shown), the effects of the deletion of amino acid residues 18-75 on the activity of the full-length hPMCA4b was investigated. The hPMCA4b(d18-75) enzyme was also inactive, indicating that the C-terminal regulatory end of the PMCA was not involved in the mechanism leading to inactivation.

Formation of the Phosphorylated Intermediate

The first step of the normal Ca2+ pump cycle involves the reaction of the enzyme with Ca2+ and ATP to form a phosphoenzyme. The ability of the hPMCA4b(d18-75)(ct120) mutant to form a phosphorylated intermediate was investigated. Fig. 3 shows that two bands corresponding to the endogenous PMCA and sarco/endoplasmic reticulum Ca2+ pumps were observed when membranes from COS-1 cells transfected with the empty vector were phosphorylated with ATP in the presence of Ca2+ plus La3+. As expected an additional band in the molecular mass region of 120 kDa was observed in membranes containing the hPMCA4b(ct120) enzyme. The phosphorylation pattern of membranes containing the hPMCA4b(d18-75)(ct120) protein was similar to that of the control, indicating that no phosphorylation attributable to the hPMCA4b(d18-75)(ct120) mutant had occurred.


Fig. 3. Autoradiographic detection of the phosphorylated intermediate. Phosphoenzyme formation was carried out as described under ``Materials and Methods'' in the presence of 1 µM ATP, 0.02 mM CaCl2, and 0.02 mM LaCl3. 5 µg of COS-1 membranes were loaded per well. In addition to the PMCA phosphoenzyme, a phosphorylated band of lower molecular mass corresponding to the endogenous sarco/endoplasmic reticulum Ca2+ pump is observed.
[View Larger Version of this Image (56K GIF file)]



DISCUSSION

In the present work we have investigated the functional consequences of a deletion in the N-terminal region of the hPMCA4b between the initial methionine and the first transmembrane domain. Mutant hPMCA4b(d18-75)(ct120) was expressed in amounts comparable with those of the hPMCA4b(ct120), indicating that the N-terminal deletion did not significantly affect the level of expression of the PMCA. The measurements of Ca2+ transport and ATP hydrolysis indicated that the mutant protein was unable to perform any of these functions. In addition, no detectable amounts of phosphoenzyme were formed by the hPMCA4b(d18-75)(ct120) enzyme. Thus the lack of Ca2+ transport and ATPase activities of mutant hPMCA4b(d18-75)(ct120) could be ascribed to its inability to react with Ca2+ and ATP to form the phosphoenzyme.

Deletion of several amino acid residues could result in alterations of the folding or insertion in the membrane of the mutant protein. Although this possibility cannot be discarded, several observations suggest that this may not be the case of the hPMCA4b(d18-75)(ct120) mutant: (i) the expressed hPMCA4b(d18-75)(ct120) protein was always found associated with membranes, and after cell lysis it was recovered in the microsomal fraction, (ii) immunoblots of membranes from COS-1 cells transfected with the hPMCA4b(d18-75)(ct120) DNA showed only one major product of about 114 kDa in amounts similar to those of the hPMCA4b(ct120), indicating that both proteins were equally stable to degradation by intracellular proteases, and (iii) digestion with trypsin and immunoblotting of the hPMCA4b(ct120) and the hPMCA4b(d18-75)(ct120) revealed similar proteolytic fragments, suggesting that both proteins exposed the same limited number of sites to the protease.

Early analysis by SDS-polyacrylamide gel electrophoresis of the proteolytic fragments produced by treatment of red cell membranes with trypsin has shown that the protease acts on several specific sites of the PMCA resulting in major peptides of 90, 81, and 76 kDa (15, 16, 17). The appearance of the 76-kDa fragment in the SDS-polyacrylamide gel electrophoresis is concomitant with a highly active PMCA. Based on these results (15) concluded that the 76-kDa polypeptide was a fully competent Ca2+ transporter and therefore that the N- and C-terminal amino acid residues missing in the 76-kDa fragment are not essential for activity. However, as mentioned in Ref. 16, the effective separation of the N-terminal fragment containing the transmembrane domains 1 and 2 from the 76-kDa product in the absence of SDS was not proved.

Recently, the expression of N-terminally and C-terminally truncated PMCA mutants allowed to directly assess the activity of the fragments produced by trypsinolysis. Although truncation of the hPMCA4b generating a C terminus similar to that of the 76 kDa fragment produces a highly active enzyme (7), a mutant starting with the N terminus of the 90-kDa polypeptide (PMCA105) is inactive (18). As was suggested previously (18), the lack of activity of the PMCA105 mutant is probably related to the absence of a large portion of the pump containing the first two transmembrane domains and the region highly conserved in all P-ATPases, which has been called the transducing domain. Results in this paper show that a smaller deletion between the N terminus and the first transmembrane domain, a region previously assumed irrelevant for the function of the enzyme, suffices for inactivation. Studies of mutants with smaller deletions and substitutions of amino acids in the N-terminal region will be needed to obtain a more precise knowledge of the residues involved and their role during Ca2+ transport by the PMCA.


FOOTNOTES

*   This work was supported in part by the Consejo Nacional de Investigaciones Científicas y Tecnológicas, Fundación Antorchas, the National Institutes of Health Grant GM28835, and National Science Foundation Grant INT 93-02981. The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§   To whom correspondence should be addressed. Fax: 54-1-962-5457; E-mail rvadamo{at}criba.edu.ar.
1   The abbreviations used are: PMCA, Ca2+ pump from plasma membranes; hPMCA4b, human PMCA isoform 4b (the hPMCA4b has also been called hPMCA4CI; Ref. 2).

REFERENCES

  1. Lutsenko, S., Kaplan, J. H. (1995) Biochemistry 34, 15607-15613 [CrossRef][Medline] [Order article via Infotrieve]
  2. Carafoli, E. (1994) FASEB J. 8, 993-1002 [Abstract]
  3. Adamo, H. P., Caride, A. J., Penniston, J. T. (1992) J. Biol. Chem. 267, 14244-14249 [Abstract/Free Full Text]
  4. James, P., Zvaritch, E., Shakhparanov, M., Penniston, J. T., Carafoli, E. (1987) Biochem. Biophys. Res. Commun. 149, 7-12 [CrossRef][Medline] [Order article via Infotrieve]
  5. Filoteo, A. G., Gorski, J. P., Penniston, J. T. (1987) J. Biol. Chem. 262, 6526-6530 [Abstract/Free Full Text]
  6. James, P., Maeda, M., Fischer, R., Verma, A. K., Krebs, J., Penniston, J. T., Carafoli, E. (1988) J. Biol. Chem. 263, 2905-2910 [Abstract/Free Full Text]
  7. Enyedi, A., Verma, A. K, Filoteo, A. G., Penniston, J. T. (1993) J. Biol. Chem. 268, 10621-10626 [Abstract/Free Full Text]
  8. Adamo, H. P., Verma, A. K., Sanders, M. A., Heim, R., Salisbury, J. L., Wieben, E. D., Penniston, J. T. (1992b) Biochem. J. 285, 791-797
  9. Gluzman, Y. (1981) Cell 23, 175-182 [CrossRef][Medline] [Order article via Infotrieve]
  10. Adamo, H. P., Filoteo, A. G., Enyedi, A., Penniston, J. T. (1995) J. Biol. Chem. 270, 30111-30114 [Abstract/Free Full Text]
  11. Laemmli, U. K. (1970) Nature 227, 680-685 [CrossRef][Medline] [Order article via Infotrieve]
  12. Fabiato, A., Fabiato, F. (1979) J. Physiol. (Paris) 75, 463-505 [Medline] [Order article via Infotrieve]
  13. Richards, D. E., Rega, A., Garrahan, P. J. (1978) Biochim. Biophys. Acta 511, 194-201 [Medline] [Order article via Infotrieve]
  14. Luterbacher, S., Schatzmann, H. J. (1983) Experientia 39, 311-318 [Medline] [Order article via Infotrieve]
  15. Sarkadi, B., Enyedi, A., Foldes-Papp, Z., Gardos, G. (1986) J. Biol. Chem. 261, 9552-9557 [Abstract/Free Full Text]
  16. Zvaritch, E., James, P., Vorherr, T., Falchetto, R., Modyanov, N., Carafoli, E. (1990) Biochemistry 29, 8070-8076 [CrossRef][Medline] [Order article via Infotrieve]
  17. Zurini, M., Krebs, J., Penniston, J. T., Carafoli, E. (1984) J. Biol. Chem. 259, 618-627 [Abstract/Free Full Text]
  18. Heim, R., Iwata, T., Zvaritch, E., Adamo, H. P., Rutishauser, B., Strehler, E. E., Guerini, D., Carafoli, E. (1992) J. Biol. Chem. 267, 24476-24484 [Abstract/Free Full Text]

©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
FASEB J.Home page
D. GUERINI, F. GUIDI, and E. CARAFOLI
Differential membrane targeting of the SERCA and PMCA calcium pumps: experiments with recombinant chimeras
FASEB J, April 1, 2002; 16(6): 519 - 528.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Daiho, K. Yamasaki, H. Suzuki, T. Saino, and T. Kanazawa
Deletions or Specific Substitutions of a Few Residues in the NH2-terminal Region (Ala3 to Thr9) of Sarcoplasmic Reticulum Ca2+-ATPase Cause Inactivation and Rapid Degradation of the Enzyme Expressed in COS-1 Cells
J. Biol. Chem., August 20, 1999; 274(34): 23910 - 23915.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grimaldi, M. E.
Right arrow Articles by Penniston, J. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grimaldi, M. E.
Right arrow Articles by Penniston, J. T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.